Company / Net Debt per Share
Avalo Therapeutics, Inc. Net Debt per Share History
FY2017-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$0.12
FY2018
5-year range
-
FY2017-FY2018
Trend
+144.9%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
0.12 in FY2018.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2018, net debt per share increased 144.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $0.12 | +144.9% |
| FY2017 | -$0.26 | - |
As of FY2018 · SEC Form 10-K · Last checked Jun 21, 2026